Toronto Dominion Bank
AMED

Toronto Dominion Bank’s Amedisys AMED Stock Holding History

Toronto Dominion Bank’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,200
Closed -$1.1M – 1926
2025
Q2 		$1.1M Hold
11,200
– – ﹤0.01% 1084
2025
Q1 		$1.04M Sell
11,200
-65,700
-85% -$6.06M ﹤0.01% 1062
2024
Q4 		$6.98M Buy
+76,900
New +$7.06M 0.01% 627

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Toronto Dominion Bank's AMED Position: Q3 2025 in Review

Toronto Dominion Bank sold out of Amedisys (AMED) in Q3 2025, closing a stake of 5,000 shares — an estimated $492K sold.

Toronto Dominion Bank first reported a position in AMED in Q3 2023 and held it in 4 quarters. The position peaked at $8.82M in Q4 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Toronto Dominion Bank reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 5,000 Amedisys shares in Q3 2025, an estimated $492K.
  • Toronto Dominion Bank first reported a position in Amedisys in Q3 2023 and held it in 4 quarters.
  • Toronto Dominion Bank's Amedisys position peaked at $8.82M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Toronto Dominion Bank's 13F filing for Q3 2025, filed 14 Nov 2025.